The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

CLEVELAND, Ohio — A new bone strength testing technology developed at Ohio University shows promise in identifying women at risk for fractures more accurately than the current standard screening ...

A bone-crushing side effect? The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression ...

GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds - ...

While women have it more often, it’s just as dangerous for men.

Silent bone loss in women refers to osteoporosis, a condition where bones weaken silently without noticeable symptoms until a ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...